XASE
USBC
Market cap60mUSD
Oct 08, Last price
0.50USD
1D
-7.28%
1Q
54.78%
Jan 2017
-28.47%
IPO
-50.43%
Name
Know Labs Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
23.68%
Rev. gr., 5y
-48.31%
Revenues
0
Net income
-24.35b
L+146,773.60%
CFO
-8m
L-40.79%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Know Labs, Inc., an American enterprise, is dedicated to the creation and market introduction of its proprietary technologies. At the heart of its operations is a technology known as Bio-RFID, which employs spectroscopy to transmit electromagnetic energy through substances or materials, thereby identifying and capturing their unique molecular signatures. This Bio-RFID system boasts adaptability, allowing for its incorporation into diverse form factors such as wearable devices, mobile applications, and stationary laboratory equipment. Its initial commercial offering leveraging Bio-RFID is a glucose monitoring product designed to furnish users with instantaneous data regarding their blood glucose concentrations. The company, initially named Visualant, Incorporated, officially adopted the name Know Labs, Inc. in May 2018. Established in 1998, Know Labs, Inc. operates from its headquarters in Seattle, Washington.
Key people
Kitty Payne
Chief Financial Officer, Treasurer, Secretary · since 2025
Peter Conley
Chief Financial Officer, Senior Vice President · since 2024
Ronald Erickson
Senior Vice President, President - Science Division · since 2025
Non-Executive Chairman of the Board, Director · since 2025
Robert Kidd
Chairman of the Board, Chief Executive Officer · since 2025
Larry Ellingson
Independent Director · since 2023
William Owens
Independent Director · since 2018
Jon Pepper
Independent Director · since 2006
Ichiro Takesako
Independent Director · since 2013
Legal address
c/o CORPORATION SERVICE COMPANY, 112 NORTH CURRY STREET
Carson City, NV 89703
US
Carson City, NV 89703
US
Headquarters
500 UNION STREET SUITE 810
Seattle, WA 98101
US
Seattle, WA 98101
US
Previous name
Know Labs, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||